Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to evaluate the safety and tolerability of Lu AF11167 in patients with schizophrenia following various repeated dosing regimens of Lu AF11167 (alone or as added treatment to risperidone).
Epistemonikos ID: 950d78c580be3096aff1d97a1b16649bae9cdcf9
First added on: May 12, 2024